19th April 2018
- 0 comments
LNC Therapeutics, a French biotech company specializing in research and development for gut microbiome-based drugs, has announced the appointment of Dr. Georges Rawadi as its new CEO. Jean-Luc Treillou, his predecessor, will become Chairman of the Board of Directors on July 1st.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage